A study on drug therapy in heart failure patients.
Not Applicable
- Conditions
- Health Condition 1: I509- Heart failure, unspecified
- Registration Number
- CTRI/2023/02/049719
- Lead Sponsor
- Anush V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patient either gender diagnosed and undergoing treatment for heart failure patients at least 3 months admitted for worsening of heart failure
Exclusion Criteria
Patients not willing to provide consent
Patients diagnosed with heart failure at the time of admission
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the pattern of heart failure medication therapy in hospitalized patientsTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method to study the difference in drug therapy between preserved and reduced ejection fraction heart failureTimepoint: 3 months